KERATOLYSIS EXFOLIATIVA ACQUIRED

This adverse event was reported 32 times

KERATOLYSIS EXFOLIATIVA ACQUIRED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL 1 0.0019
1 LAZERTINIB 1 0.0012
2 TISOTUMAB VEDOTIN 1 0.0010
3 NORETHINDRONE AND ETHINYL ESTRADIOL 1 0.0009
4 TALQUETAMAB-TGVS 1 0.0007
5 TERBINAFINE HYDROCHLORIDE TABLET 4 0.0006
6 FOSINOPIRL SODIUM 1 0.0005
7 TERBINAFINE HYDROCHLORIDE 4 0.0004
8 OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% 3 0.0004
9 OFLOXACIN OTIC SOLUTION 3 0.0004
See all drugs enriched for association with KERATOLYSIS EXFOLIATIVA ACQUIRED

KERATOLYSIS EXFOLIATIVA ACQUIRED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Allylamine Antifungal [EPC] 4 0.0006
1 Quinolone Antimicrobial [EPC] 3 0.0003
2 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
3 Anti-anginal [EPC] 2 0.0002
4 Glinide [EPC] 1 0.0001
5 Barbiturate [EPC] 1 0.0001
6 Nonergot Dopamine Agonist [EPC] 1 0.0001
7 Nitrofuran Antibacterial [EPC] 1 0.0001
8 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1 0.0000
9 Sympathomimetic-like Agent [EPC] 1 0.0000
See all drug classes enriched for association with KERATOLYSIS EXFOLIATIVA ACQUIRED